PFE Total Current Liabilities

Pfizer · Total Current Liabilities

PFE logo

PFE Total Current Liabilities

Latest reported$32.65B
PFE Quarterly Current Liabilities ($959.70M → $32.65B)
High-resolution chart · PNG

PFE total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
32,646,000,000
34,348,000,000
36,984,000,000
36,596,000,000
37,726,000,000
36,452,000,000
42,995,000,000
43,211,000,000
43,819,000,000
40,497,000,000
47,794,000,000
31,136,000,000
34,647,000,000
36,562,000,000
42,138,000,000
44,314,000,000
47,410,000,000
39,268,000,000
42,671,000,000
41,803,000,000
35,664,000,000
26,652,000,000
25,920,000,000
34,154,000,000
32,723,000,000
33,890,000,000
37,304,000,000
36,974,000,000
32,030,000,000
29,423,000,000
31,858,000,000
29,013,000,000
32,156,000,000
27,365,000,000
30,427,000,000
28,217,000,000
27,182,000,000
24,864,000,000
31,115,000,000
34,759,000,000
32,099,000,000
28,735,000,000
29,399,000,000
27,845,000,000
24,143,000,000
20,222,000,000
21,631,000,000
19,920,000,000
21,938,000,000
24,790,000,000
23,366,000,000
20,373,000,000
23,450,000,000
27,543,000,000
28,619,000,000
29,131,000,000
30,798,000,000
27,094,000,000
28,069,000,000
27,856,000,000
30,471,000,000
29,171,000,000
28,609,000,000
24,172,000,000
24,681,000,000
25,924,000,000
37,225,000,000
23,992,000,000
26,109,000,000
23,340,000,000
27,009,000,000
21,503,000,000
23,193,000,000
21,682,000,000
21,835,000,000
14,328,000,000
15,136,000,000
13,301,000,000
21,389,000,000
17,688,000,000
20,055,000,000
19,674,000,000
28,448,000,000
20,395,000,000
22,566,000,000
28,948,000,000
26,458,000,000
25,239,000,000
25,158,000,000
24,637,000,000
23,657,000,000
21,660,000,000
22,157,000,000
18,754,000,000
18,555,000,000
18,401,000,000
16,317,000,000
14,729,000,000
13,640,000,000
13,039,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.